[HTML][HTML] Epidemiology of prothrombin G20210A mutation in the Mediterranean region

MM Jadaon - Mediterranean journal of hematology and infectious …, 2011 - ncbi.nlm.nih.gov
There are many genetic and acquired risk factors that are known to cause venous
thromboembolic disorders (VTE). One of these is the Prothrombin G20210A mutation, which …

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase …

B Simone, V De Stefano, E Leoncini, J Zacho… - European journal of …, 2013 - Springer
Genetic and environmental factors interact in determining the risk of venous
thromboembolism (VTE). The risk associated with the polymorphic variants G1691A of factor …

Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review

M Dziadosz, LV Baxi - Blood Coagulation & Fibrinolysis, 2016 - journals.lww.com
Distribution of hereditary thrombophilic gene mutations differs globally. Prothrombin gene
mutation G20210A is a common prothrombotic single-nucleotide polymorphism. In this …

The genetics of venous thromboembolism

R Gohil, G Peck, P Sharma - Thrombosis and haemostasis, 2009 - thieme-connect.com
We conducted a systematic and comprehensive meta-analysis on all candidate genes to
assess their genetic contribution to the aetiology of venous thromboembolism …

Influence of blood count, cardiovascular risks, inherited thrombophilia, and JAK2 V617F burden allele on type of thrombosis in patients with Philadelphia chromosome …

I Horvat, A Boban, R Zadro, MR Antolic… - … Myeloma and Leukemia, 2019 - Elsevier
Introduction Thrombosis is the most common complication in Philadelphia chromosome
negative (Ph−) myeloproliferative neoplasms patients. Patients and Methods In a cohort of …

[HTML][HTML] Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region

MM Jadaon - Mediterranean journal of hematology and infectious …, 2011 - ncbi.nlm.nih.gov
Venous thromboembolic disorders (VTE) are serious disorders with high morbidity and
mortality rates. Many genetic and acquired risk factors were identified to cause VTE. The …

Factor V Leiden is associated with higher risk of deep venous thrombosis of large blood vessels

T Arsov, D Miladinova, M Spiroski - Croatian medical journal, 2006 - hrcak.srce.hr
Aim: To determine the prevalence of factor V Leiden mutation in patients with different
presentation of venous thromboembolic disease and healthy individuals in the Republic of …

Frequency and association of 1691 (G> A) FVL, 20210 (G> A) PT and 677 (C> T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina

A Jusić-Karić, R Terzić, Z Jerkić, A Avdić… - Balkan Journal of …, 2016 - sciendo.com
ABSTRACT The 1691 (G> A) factor V Leiden (FVL) and 20210 (G> A) prothrombin (PT)
mutations are the two most common genetic risk factors in venous thromboembolism. The …

Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs

WY Almawi, SH Keleshian, L Borgi, NA Fawaz… - Journal of thrombosis …, 2005 - Springer
Abstract Background: Factor V G1691A (FV-Leiden) and prothrombin (PRT) G20210A single
nucleotide polymorphisms (SNPs) are major inherited risk factors of venous …

Genetics of suspected thrombophilia in Serbian females with infertility, including three cases, homozygous for FII 20210A or FV 1691A mutations

J Djurovic, O Stojkovic, J Todorovic, A Brajic… - Human …, 2017 - Taylor & Francis
Reproductive failure (recurrent foetal loss, unexplained infertility and IVF implantation
failure) may be, in a number of cases, explained by thrombophilia, either acquired or …